Lambert, J.
Steelandt, T.
Heywang-Köbrunner, S. H.
Gieraerts, K.
Van Den Berghe, I.
Van Ongeval, Ch.
Casselman, J. W. http://orcid.org/0000-0002-8970-6979
Article History
Received: 13 May 2020
Revised: 22 September 2020
Accepted: 8 October 2020
First Online: 18 January 2021
Compliance with ethical standards
:
: The scientific guarantor of this publication is J.W. Casselman.
: The authors of this manuscript declare relationships with the following companies:J.W. Casselman provides presentations for Philips and receives clients for Philips. Also, he organizes workshops for Leica-Devicor Mammotome. None of the other authors have any conflict of interest.
: No complex statistical methods were necessary for this paper.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained.
: A minor subgroup of our study (52 patients) was already included in a prior multicenter study by Heywang-Köbrunner SH et al, Eur Radiol (2001) 11:531-546. Also, data of the VABB procedures of these 52 patients was used in the three following publications: Perlet et al, Eur Radiol. (2002) 12(6):1463–70; Hefler et al, Eur Radiol (2003) 13(2):344–6 and Perlet et al, Cancer (2006) 106(5):982–90. Our new dataset includes 507 additional patients for a total of 600 biopsies, now in a single-center setting, with a much more extensive follow-up available for analysis of the false negative rate.
: • retrospective• observational• performed at one institution